Search

Meir Preis Phones & Addresses

  • Hanover, NH
  • 76 Greensboro Rd, Hanover, NH 03755

Work

Company: DARTMOUTH-HITCHCOCK MEDICAL CENTER Address: 1 Medical Center Dr, Lebanon, NH 03756 Phones: (603) 650-5000 (603) 335-8475

Education

Degree: Associate degree or higher

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 2010

Specialities

Internal Medicine

Professional Records

Medicine Doctors

Meir Preis Photo 1

Dr. Meir Preis, Lebanon NH - MD (Doctor of Medicine)

View page
Specialties:
Internal Medicine
Address:
1 Medical Center Dr, Lebanon, NH 03756
(603) 653-9500 (Phone), (603) 650-7791 (Fax)

DARTMOUTH-HITCHCOCK MEDICAL CENTER
1 Medical Center Dr, Lebanon, NH 03756
(603) 650-5000 (Phone), (603) 335-8475 (Fax)
Certifications:
Internal Medicine, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1 Medical Center Dr, Lebanon, NH 03756

DARTMOUTH-HITCHCOCK MEDICAL CENTER
1 Medical Center Dr, Lebanon, NH 03756

Dartmouth - Hitchcock Medical Center
1 Medical Center Drive, Lebanon, NH 03756
Meir Preis Photo 2

Meir Preis

View page
Specialties:
Internal Medicine
Education:
Technion Israel Institute Of Technology (2003)
Meir Preis Photo 3

Meir Preis, Lebanon NH

View page
Specialties:
Internist
Address:
1 Medical Center Dr, Lebanon, NH 03756

Business Records

Name / Title
Company / Classification
Phones & Addresses
Meir Preis
Md Phd
Perioperative Services
Services-Misc
1 Medical Ctr Dr, Lebanon, NH 03756

Publications

Us Patents

Methods For Determining Response To Neoadjuvant Therapy And Survival Using Microrna-10B

View page
US Patent:
20120021415, Jan 26, 2012
Filed:
Jun 29, 2011
Appl. No.:
13/172047
Inventors:
Lorenzo F. Sempere - Lebanon NH, US
Murray Korc - Hanover NH, US
Meir Preis - Hanover NH, US
Assignee:
TRUSTEES OF DARTMOUTH COLLEGE - HANOVER NH
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
The present invention provides methods for determining response to neoadjuvant therapy and metastasis-free survival in pancreatic ductal adenocarcinoma based upon the level of microRNA expression and optionally the presence of a protein cancer cell marker in biological samples such as formalin-fixed paraffin-embedded specimens using in situ hybridization and optionally an immunohistochemical assay.
Meir Preis from Hanover, NH, age ~54 Get Report